Mental retardation screening: Difference between revisions
m Bot: Removing from Primary care |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mental retardation}} | {{Mental retardation}} | ||
{{CMG}}; {{AE}} {{Chelsea}} | |||
==Overview== | |||
== References == | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
{{ | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | |||
OR | |||
According to the [guideline name], screening for [disease name] is not recommended. | |||
OR | |||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | |||
*[Condition 1] | |||
*[Condition 2] | |||
*[Condition 3] | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | {{WH}} |
Revision as of 22:18, 6 July 2021
Mental retardation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mental retardation screening On the Web |
American Roentgen Ray Society Images of Mental retardation screening |
Risk calculators and risk factors for Mental retardation screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chelsea Mae Nobleza, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]